Spyre Therapeutics (SYRE) Return on Capital Employed Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | 13,159.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,159.00 |
| Dec 31, 2025 | 9,113.00 |
| Sep 30, 2025 | 6,071.00 |
| Jun 30, 2025 | 6,576.00 |
| Mar 31, 2025 | 4,823.00 |
| Dec 31, 2024 | 2,081.00 |
| Sep 30, 2024 | 573.00 |
| Jun 30, 2024 | 1,334.00 |
| Mar 31, 2024 | -1,100.00 |
| Dec 31, 2023 | -4,258.00 |
| Sep 30, 2023 | -6,563.00 |
| Jun 30, 2023 | 33,857.00 |
| Mar 31, 2023 | -1,727.00 |
| Dec 31, 2022 | -1,748.00 |
| Sep 30, 2022 | -2,671.00 |
| Jun 30, 2022 | -5,275.00 |
| Mar 31, 2022 | -2,948.00 |
| Dec 31, 2021 | 466.00 |
| Sep 30, 2021 | -370.00 |
| Jun 30, 2021 | 669.00 |
| Mar 31, 2021 | 80.00 |
| Dec 31, 2020 | -475.00 |
| Sep 30, 2020 | -866.00 |
| Jun 30, 2020 | -4,057.00 |
| Mar 31, 2020 | -10,441.00 |
| Dec 31, 2019 | -7,623.00 |
| Sep 30, 2019 | -5,020.00 |
| Jun 30, 2019 | -2,510.00 |
| Mar 31, 2019 | -1,978.00 |